Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20208964rdf:typepubmed:Citationlld:pubmed
pubmed-article:20208964lifeskim:mentionsumls-concept:C0001044lld:lifeskim
pubmed-article:20208964lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:20208964lifeskim:mentionsumls-concept:C0086728lld:lifeskim
pubmed-article:20208964pubmed:issue4lld:pubmed
pubmed-article:20208964pubmed:dateCreated2010-3-8lld:pubmed
pubmed-article:20208964pubmed:abstractTextObidoxime is the only one reactivator of acetylcholinesterase (AChE) approved in Czech Republic for the treatment of nerve agent and pesticide poisonings for civilian sector. Due to the fact that misuse of nerve agents by terrorists or by an accidental poisoning by farmers is possible, re-evaluation of its universality is needed. It is also needed by the fact that clinical findings considering this oxime are controversial.lld:pubmed
pubmed-article:20208964pubmed:languageenglld:pubmed
pubmed-article:20208964pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:citationSubsetIMlld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20208964pubmed:statusMEDLINElld:pubmed
pubmed-article:20208964pubmed:monthDeclld:pubmed
pubmed-article:20208964pubmed:issn1213-8118lld:pubmed
pubmed-article:20208964pubmed:authorpubmed-author:DohnalVlastim...lld:pubmed
pubmed-article:20208964pubmed:authorpubmed-author:PatockaJiriJlld:pubmed
pubmed-article:20208964pubmed:authorpubmed-author:KucaKamilKlld:pubmed
pubmed-article:20208964pubmed:authorpubmed-author:MusilekKamilKlld:pubmed
pubmed-article:20208964pubmed:authorpubmed-author:PohankaMirosl...lld:pubmed
pubmed-article:20208964pubmed:issnTypePrintlld:pubmed
pubmed-article:20208964pubmed:volume153lld:pubmed
pubmed-article:20208964pubmed:ownerNLMlld:pubmed
pubmed-article:20208964pubmed:authorsCompleteYlld:pubmed
pubmed-article:20208964pubmed:pagination259-62lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:meshHeadingpubmed-meshheading:20208964...lld:pubmed
pubmed-article:20208964pubmed:year2009lld:pubmed
pubmed-article:20208964pubmed:articleTitleReactivation potency of the acetylcholinesterase reactivator obidoxime is limited.lld:pubmed
pubmed-article:20208964pubmed:affiliationCenter of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. kucakam@pmfhk.czlld:pubmed
pubmed-article:20208964pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20208964pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:20208964pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed